Evidence map›Paper›PMID 38449379›Full record

ArticleInfection control and hospital epidemiology2024

Ian P Hennessee, Kaitlin Forsberg, Susan E Beekmann, Philip M Polgreen, Jeremy A W Gold, Meghan Lyman

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Surveillance for Candida auris - United States, 2022-2024.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2026
    Article
  2. Article
  3. Yeast identification, antifungal susceptibility testing, andJournal of clinical microbiology · 2026
    Article
  4. Infection control and hospital epidemiology · 2026
    Article
  5. Infection prevention and control ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Review
  6. Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ian P HennesseeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-8807-9566
Kaitlin ForsbergMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0002-5779-2446
Susan E BeekmannUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.ORCID 0000-0003-0278-506X
Philip M PolgreenUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.ORCID 0000-0002-0630-5898
Jeremy A W GoldMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0002-5054-7616
Meghan LymanMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-7925-2232

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Intramural CDC HHS CC999999NIDDK NIH HHS P30 DK054759
6 · The paper itself

Abstract

We surveyed members of the Emerging Infections Network about

Indexed as

Candida aurisCandidiasisHealth FacilitiesMass ScreeningCandidaCommunicable Diseases, EmergingCross InfectionHumansSurveys and QuestionnairesUnited States

Identifiers

PMID38449379
PMCPMC11234895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.